Viewing Study NCT05468359


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-03-01 @ 12:53 AM
Study NCT ID: NCT05468359
Status: SUSPENDED
Last Update Posted: 2025-05-25
First Post: 2022-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Sponsor: St. Jude Children's Research Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module